BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38236008)

  • 1. Point-of-care tests for human papillomavirus detection in uterine cervical samples: A review of advances in resource-constrained settings.
    Gupta R; Gupta S
    Indian J Med Res; 2023 Nov; 158(5&6):509-521. PubMed ID: 38236008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A direct comparison of four high-risk human papillomavirus tests versus the cobas test: Detecting CIN2+ in low-resource settings.
    Xue P; Gao LL; Yin J; Han LL; Zhao J; Li L; Seery S; Han XY; Li TY; Jiang Y; Chen W; Shen J
    J Med Virol; 2019 Jul; 91(7):1342-1350. PubMed ID: 30854653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    Mwenda V; Bor JP; Nyangasi M; Njeru J; Olwande S; Njiri P; Arbyn M; Weyers S; Tummers P; Temmerman M
    PLoS One; 2023; 18(5):e0286202. PubMed ID: 37228154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
    Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
    BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
    Li T; Chen S; Li X; Wu Z; Zhao Y; Cui J; Liu B; Chen F; Zhang X; Qiao Y; Chen W
    Virol J; 2023 Jun; 20(1):116. PubMed ID: 37280665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research.
    Desai KT; de Sanjosé S; Schiffman M
    Cancer Prev Res (Phila); 2023 Dec; 16(12):649-651. PubMed ID: 38037384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly.
    Rebolj M; Sargent A; Njor SH; Cuschieri K
    Int J Cancer; 2023 Jul; 153(1):8-19. PubMed ID: 36385698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population.
    Cuzick J; Cadman L; Ahmad AS; Ho L; Terry G; Kleeman M; Lyons D; Austin J; Stoler MH; Vibat CRT; Dockter J; Robbins D; Billings PR; Erlander MG
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1053-1059. PubMed ID: 28223432
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality assurance in human papillomavirus testing for primary cervical screening.
    Cuschieri K; Fellner MD; Arroyo Mühr LS; Padalko E; Correa RM; Dillner J; Gultekin M; Picconi MA
    Int J Gynecol Cancer; 2023 May; 33(5):802-811. PubMed ID: 36914171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women.
    Snyman LC; Richter KL; Lukhwareni A; Dreyer G; Botha MH; Van Der Merwe FH; Visser C; Dreyer G
    Int J Gynecol Cancer; 2023 May; 33(5):669-675. PubMed ID: 36650011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical screening and human papillomavirus.
    Sheary B; Dayan L
    Aust Fam Physician; 2005 Jul; 34(7):578-80. PubMed ID: 15999169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
    Magdi R; Elshafeey F; Elshebiny M; Kamel M; Abuelnaga Y; Ghonim M; Nabhan A;
    Int J Gynaecol Obstet; 2021 Jan; 152(1):12-18. PubMed ID: 33124048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.